Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
10.3389/fendo.2021.609110
Saved in:
Main Authors: | Wong, Chloe, Lee, Ming Hui, Yaow, Clyve Yu Leon, Chin, Yip Han, Goh, Xin Lei, Ng, Cheng Han, Lim, Amanda Yuan Ling, Muthiah, Mark Dhinesh, Khoo, Chin Meng |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Review |
Language: | English |
Published: |
FRONTIERS MEDIA SA
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206120 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review
by: Ng, Nicholas Beng Hui, et al.
Published: (2022) -
Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis
by: Wong, Chloe, et al.
Published: (2021) -
The role of arginine vasopressin in diabetes-associated glucagons secretion
by: Sirintorn Yibchok-anun, et al.
Published: (2008) -
MTORC1 inhibition drives crinophagic degradation of glucagon
by: Rajak, Sangam, et al.
Published: (2022) -
Synaptotagmin-7 as a positive regulator of glucose-induced glucagon-like peptide-1 secretion in mice
by: Gustavsson, N., et al.
Published: (2014)